Porphyromonas gingivalis under palmitate-induced obesogenic microenvironment modulates the inflammatory transcriptional signature of macrophage-like cells

PLoS One. 2023 Jun 29;18(6):e0288009. doi: 10.1371/journal.pone.0288009. eCollection 2023.

Abstract

Metabolic diseases and low-grade chronic inflammation are interconnected: obese persons are at higher risk of developing periodontitis. However, the molecular mechanisms involved in the development and progression of periodontitis in an obesogenic microenvironment in response to periodontopathogens are still lacking. This study aims to investigate the combined effects of palmitate and Porphyromonas gingivalis on the secretion of pro-inflammatory cytokines and on transcriptional landscape modifications in macrophage-like cells. U937 macrophage-like cells were treated with palmitate and stimulated with P. gingivalis for 24h. Cytokines IL-1β, TNF-α and IL-6 were measured by ELISA in the culture medium and cell extracted RNA was submitted to a microarray analysis followed by Gene Ontology analyses. P. gingivalis, in presence of palmitate, potentiated IL-1β and TNF-α secretion in comparison to palmitate alone. Gene Ontology analyses also revealed that the combination palmitate-P. gingivalis potentiated the number of gene molecular functions implicated in the regulation of immune and inflammatory pathways compared to macrophages treated with palmitate alone. Our results provide the first comprehensive mapping of gene interconnections between palmitate and P. gingivalis during inflammatory responses in macrophage-like cells. These data highlight the importance of considering systemic conditions, specifically obesogenic microenvironment, in the management of periodontal disease in obese patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines
  • Humans
  • Macrophages
  • Obesity / genetics
  • Palmitates / pharmacology
  • Porphyromonas gingivalis*
  • Tumor Necrosis Factor-alpha*
  • U937 Cells

Substances

  • Tumor Necrosis Factor-alpha
  • Cytokines
  • Palmitates

Grants and funding

This study was supported by a grant to VPH from the Fondation de l’Université Laval (Fonds Émile-Beaulieu), Quebec City, Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.